Cheryl Hecht, LCSW in Accord, NY - Social Worker

Cheryl Hecht, LCSW is a Social Worker - Clinical based in Accord, New York. Cheryl Hecht is licensed to practice in New York (license number 033098) and her current practice location is 360 Mill Hook Rd, Accord, New York. She can be reached at her office (for appointments etc.) via phone at (845) 772-2799.

NPI number for Cheryl Hecht is 1427676444 and her current mailing address is 360 Mill Hook Rd, Accord, New York. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1427676444.

Contact Information

	Cheryl Hecht, LCSW
	360 Mill Hook Rd, Accord, NY 12404-5819
	(845) 772-2799
	Not Available

Healthcare Provider's Profile

Full Name	Cheryl Hecht
Gender	Female
Speciality	Social Worker - Clinical
Location	360 Mill Hook Rd, Accord, New York
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1427676444
Provider Enumeration Date: 07/07/2020
Last Update Date: 07/07/2020

Medical Identifiers

Medical identifiers for Cheryl Hecht such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1427676444	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
1041C0700X	Social Worker - Clinical	(* (Not Available))	Secondary
1041C0700X	Social Worker - Clinical	033098 (New York)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Cheryl Hecht is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Cheryl Hecht, LCSW 360 Mill Hook Rd, Accord, NY 12404-5819 Ph: () -	Cheryl Hecht, LCSW 360 Mill Hook Rd, Accord, NY 12404-5819 Ph: (845) 772-2799

News Archive

Pearl Therapeutics presents data supporting development of PT003 combination bronchodilator product

Pearl Therapeutics Inc., a company developing clinically differentiated double and triple combination therapies for the treatment of highly prevalent chronic respiratory diseases, presented results from four studies that provide support for further development of PT003, the company's fixed dose combination of glycopyrrolate and formoterol delivered via a pressurized hydrofluoroalkane metered dose inhaler (HFA-MDI).

Morphine withdrawal enhances hepatitis C virus (HCV) replicon expression

Researchers at the University of Pennsylvania have demonstrated that morphine withdrawal complicates hepatitis C by suppressing IFN-alpha-mediated immunity and enhancing virus replication.

One single genomic fingerprinting could potentially miss smaller, more aggressive prostate tumors

While the majority of prostate cancers are slow growing and not fatal, some are aggressive and lethal.

Pilgrimage to Mecca comes with a few medical risks

The Hajj or Haj is the Pilgrimage to Mecca (or, "Makkah") and is the fifth of the "Five Pillars of Islam". Every able-bodied Muslim who can afford to do so is obliged to make the pilgrimage to Mecca at least once in a lifetime. Later this month about three million Muslims will gather for this major pilgrimage. But two doctors in this week's BMJ warn that the Hajj carries considerable health risks if the pilgrim is unprepared.

Cheryl Hecht, LCSW - Clinical Social Worker in Accord, NY